12 July 2024 - PHARMAC is looking to increase access to five medicines for a number of cancers, including kidney and lung cancers, and other health conditions.

“We’re looking to widen access to chemotherapy and a type of targeted cancer treatment for people who don’t currently have any other treatment options available,” says Geraldine MacGibbon, Pharmac Director, Pharmaceuticals

“We’re also proposing to fund lanreotide for the first time for people with neuroendocrine cancer, cancer related bowel obstruction, and a growth disorder called acromegaly. Lanreotide is easier to administer than other funded treatments.”

Read PHARMAC press release